US approves second COVID-19 vaccine Moderna for emergency use

The U.S. Food and Drug Administration has authorized American drugmaker Moderna’s COVID-19 vaccine for emergency use in the United States of America.

Moderna becomes the second COVID-19 vaccine to receive FDA emergency use authorization. The FDA Had approved Pfizer-BioNTech’s vaccine for emergency use earlier this month.

The vaccine, from U.S. drugmaker Moderna, was developed with the National Institutes of Health.

Earlier on Friday,  U.S. Vice President Mike Pence and U.S. House Speaker Nancy Pelosi received their first COVID-19 vaccinations.

The two vaccines work “better than we almost dared to hope,” National Institutes of Health Director Dr. Francis Collins said. “Science is working here; science has done something amazing.”

After the approval, the U.S. drugmaker will begin transporting millions of doses for health workers and nursing home residents, and it could arrive Monday.